Sayo Kawai

Sayo Kawai

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2019 in Communications Biology
Verified
Journal Article
Open access
PDF file
MNMasahiro Nakatochi
Masahiro Nakatochi
MKMasahiro Kanai
Masahiro Kanai
Akiyoshi NakayamaAkiyoshi Nakayama
Akiyoshi Nakayama
AHAsahi Hishida
Asahi Hishida
YKYusuke Kawamura
Yusuke Kawamura
HMHirotaka Matsuo
Hirotaka Matsuo
Gout is a common arthritis caused by elevated serum uric acid (SUA) levels. Here we investigated loci influencing SUA in a genome-wide meta-analysis with 121,745 Japanese subjects. We identified 8948 variants at 36 genomic loci (P<5 × 10–8) including eight novel loci. Of these, missense variants of SESN2 and PNPLA3 were predicted to be damaging to the function of these proteins; another five loci—TMEM18, TM4SF4, MXD3-LMAN2, PSORS1C1-PSORS1C2, and HNF4A—are related to cell metabolism, proliferation, or oxidative stress; and the remaining locus, LINC01578, is unknown. We also identified 132 correlated genes whose expression levels are associated with SUA-increasing alleles. These genes are enriched for the UniProt transport term, suggesting the importance of transport-related genes in SUA regulation. Furthermore, trans-ethnic meta-analysis across our own meta-analysis and the Global Urate Genetics Consortium has revealed 15 more novel loci associated with SUA. Our findings provide insight into the pathogenesis, treatment, and prevention of hyperuricemia/gout.

22 February 2019 in SLEEP
Verified
Journal Article
Closed access
PDF file
TNTakeshi Nishiyama
Takeshi Nishiyama
MNMasahiro Nakatochi
Masahiro Nakatochi
AGAtsushi Goto
Atsushi Goto
MIMotoki Iwasaki
Motoki Iwasaki
THTsuyoshi Hachiya
Tsuyoshi Hachiya
SSSadao Suzuki
Sadao Suzuki
Usual sleep duration has substantial heritability and is associated with various physical and psychiatric conditions as well as mortality. However, for its genetic locus, only PAX8 and VRK2 has been replicated in previous genome-wide association studies (GWAS). We conducted a GWAS meta-analysis of self-reported usual sleep duration using three population-based cohorts totaling 31,230 Japanese individuals. A genome-wide significant locus was identified at 12q24 (P-value < 5.0×10-8). Subsequently, a functional variant in the ALDH2 locus, rs671, was replicated in an independent sample of 5,140 Japanese individuals (P-value = 0.004). The association signal, however, disappeared after adjusting for alcohol consumption, indicating the possibility that the rs671 genotype modifies sleep duration via alcohol consumption. This hypothesis explained a modest genetic correlation observed between sleep duration and alcohol consumption (rG = 0.23). A Mendelian randomization analysis using rs671 and other variants as instrumental variables confirmed this by showing a causal effect of alcohol consumption, but not of coffee consumption on sleep duration. Another genome-wide significant locus was identified at 5q33 after adjusting for drinking frequency. However, this locus was not replicated, nor was the PAX8 and VRK2 . Our study has confirmed a functional ALDH2 variant, rs671, most strongly influencing on usual sleep duration possibly via alcohol consumption in the Japanese population, and presumably in East Asian populations. This highlights the importance of considering the involvement of alcohol consumption in future GWAS of usual sleep duration, even in non-East Asian populations, where rs671 is monomorphic.

27 August 2021 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
SKSayo Kawai
Sayo Kawai
CWChaochen Wang
Chaochen Wang
YLYingsong Lin
Yingsong Lin
TSTae Sasakabe
Tae Sasakabe
MOMasumi Okuda
Masumi Okuda
SKShogo Kikuchi
Shogo Kikuchi
Helicobacter pylori (H. pylori) infection is considered the leading cause of gastric cancer. Gastric cancer is currently a common cancer with high incidence and mortality rates, but it is expected that the incidence rate will gradually decrease as the H. pylori infection prevalence decreases in the future. When evaluating the effectiveness of gastric cancer prevention strategies, it is essential to note the differences in long‐term cumulative risks between H. pylori‐infected and uninfected populations, but this has not yet been precisely evaluated. In our study, we aimed to estimate the cumulative incidence risks of developing gastric cancer from birth to 85 years among H. pylori‐infected and uninfected populations by using population‐based cancer registry data and birth year‐specific H. pylori infection prevalence rates. Death from gastric cancer and other causes of death were considered in the estimations of the adjusted cumulative incidence risks stratified by sex and H. pylori infection status. After performing 5000 Monte Carlo simulations with repeated random sampling using observed cancer incidence in selected three prefectures (Fukui, Nagasaki, Yamagata) of prefectural population‐based cancer registry in Japan, the mean adjusted cumulative incidence risk for gastric cancer in the H. pylori‐infected population was 17.0% for males and 7.7% for females and 1.0% for males and 0.5% for females in the uninfected population. These results calculated with Japanese cancer registry data may be useful in considering and evaluating future prevention strategies for gastric cancer in Japan.

1 October 2019 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
SKSayo Kawai
Sayo Kawai
KAKensuke Arai
Kensuke Arai
YLYingsong Lin
Yingsong Lin
TNTakeshi Nishiyama
Takeshi Nishiyama
TSTae Sasakabe
Tae Sasakabe
SKShogo Kikuchi
Shogo Kikuchi

17 December 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
TTTakashi Tamura
Takashi Tamura
MNMariko Naito
Mariko Naito
KMKenta Maruyama
Kenta Maruyama
MTMineko Tsukamoto
Mineko Tsukamoto
TSTae Sasakabe
Tae Sasakabe
KWKenji Wakai
Kenji Wakai
Although self-rated health (SRH) independently predicts mortality, the biological background of this association remains unexplained. This study aimed to examine the association between SRH and serum high-sensitivity C-reactive protein (hsCRP) level. Subjects were 899 participants aged 35–69 years (237 men and 662 women) in the Daiko Study, part of the Japan Multi-Institutional Collaborative Cohort Study. They were enrolled from 2008 to 2010. Of the subjects, 666 participated in a second survey 5 years later. Lifestyle factors and SRH were assessed using a self-administered questionnaire. Serum hsCRP level was measured using a latex-enhanced immunonephelometric assay. The association between SRH and serum hsCRP level was evaluated using a general linear model with covariates. We further longitudinally investigated whether higher serum hsCRP level at baseline predicts poor SRH after 5 years using an unconditional logistic regression model. A higher serum hsCRP level was significantly associated with poor SRH at baseline after adjusting for covariates (p for trend = 0.023). The age- and sex-adjusted odds ratio and 95% confidence interval (CI) for poor SRH after 5 years was 1.45 (95% CI: 0.76–2.78) for the highest tertile compared with the lowest tertile of serum hsCRP level at baseline with a significant linear trend (p for trend = 0.033), although the risk increase disappeared after adjustment for other covariates. The present study demonstrated that poor SRH is cross-sectionally associated with higher serum hsCRP level. However, the longitudinal data did not support the relationship between serum hsCRP level at baseline and future SRH. Further longitudinal studies that include data on mortality and multiple inflammatory markers are warranted to elucidate the possible role of low-grade inflammation in the association between SRH and mortality risk.

4 February 2024 in Cancer Science
Verified
Journal Article
Open access
SKSayo Kawai
Sayo Kawai
YLYingsong Lin
Yingsong Lin
HTHiroshi Tsuge
Hiroshi Tsuge
HIHidemi Ito
Hidemi Ito
Keitaro MatsuoKeitaro Matsuo
Keitaro Matsuo
RJResearch Group for the Development and Evaluation of Cancer Prevention Strategies in Japan
Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan
Mounting evidence suggests that body mass index (BMI) is inversely associated with the risk of lung cancer. However, relatively few studies have explored this association in Asian people, who have a much lower prevalence of obesity than Caucasians. We pooled data from 10 prospective cohort studies involving 444,143 Japanese men and women to address the association between BMI and the risk of lung cancer. Study‐specific hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated in each cohort using the Cox proportional hazards model. A meta‐analysis was undertaken by combining the results from each cohort. Heterogeneity across studies was evaluated using Cochran's Q and I2statistics. During 5,730,013 person‐years of follow‐up, 6454 incident lung cancer cases (4727 men and 1727 women) were identified. Baseline BMI was inversely associated with lung cancer risk in men and women combined. While leanness (BMI <18.5) was associated with a higher risk of lung cancer (HR 1.35; 95% CI, 1.16–1.57), overweight and obesity were associated with a lower risk, with HRs of 0.77 (95% CI, 0.71–0.84) and 0.69 (95% CI, 0.45–1.07), respectively. Every 5 kg/m2 increase in BMI was associated with a 21% lower risk of lung cancer (HR 0.79; 95% CI, 0.75–0.83; p < 0.0001). Our pooled analysis indicated that BMI is inversely associated with the risk of lung cancer in the Japanese population. This inverse association could be partly attributed to residual confounding by smoking, as it was more pronounced among male smokers.